Damora Therapeutics Inc.

DMRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.20

-$0.65 (-2.84%)

Sep 22, 2026, 2:33 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-209.84M	-21.44M	-38.35M	-61.62M	-51.75M	-34.84M
Depreciation & Amortization	34K	181K	830K	490K	441K	188K
Stock-Based Compensation	998K	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.09M	-1.34M	-2.72M	10.12M	-5.3M	-4.11M
Other Non-Cash Items	183.72M	5.3M	4.98M	6.27M	5.63M	1.04M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	18.36M	-2.67M	-4.37M	11.94M	-6.62M	-4.59M
Operating Cash Flow	-6.73M	-18.62M	-36.91M	-42.93M	-52.31M	-38.2M
Capital Expenditures	n/a	n/a	n/a	-196K	-223K	n/a
Cash Acquisitions	-17.37M	n/a	83K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-25.94M	-44.87M	-84.21M	n/a
Sales Maturities Of Investments	n/a	11.65M	48.18M	57.45M	36.38M	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-17.37M	11.65M	22.33M	12.38M	-48.05M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	33K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	266.84M	n/a	2.88M	507K	n/a	187.39M
Net Cash Flow	243.45M	-7.29M	-11.32M	-29.78M	-101.02M	152.29M
Free Cash Flow	-6.73M	-18.62M	-36.91M	-43.13M	-52.53M	-38.2M
Adj. Free Cash Flow	-7.72M	-18.62M	-36.91M	-43.13M	-52.53M	-38.2M
Maintenance CapEx	n/a	n/a	n/a	-196K	-223K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-6.73M	-18.62M	-36.91M	-43.13M	-52.53M	-38.2M